Skip to main content
Provectus Biopharmaceuticals, Inc. (PVCT)
OTCMKTS · Delayed Price · Currency is USD
0.114
-0.003 (-2.56%)
Jan 17, 2025, 4:00 PM EST

PVCT Revenue

Provectus Biopharmaceuticals had revenue of $109.75K in the quarter ending September 30, 2024, with 57.38% growth. This brings the company's revenue in the last twelve months to $723.92K, up 20.36% year-over-year. In the year 2023, Provectus Biopharmaceuticals had annual revenue of $557.71K, down -43.61%.

Revenue (ttm)
723.92K
Revenue Growth
+20.36%
P/S Ratio
64.82
Revenue / Employee
180.98K
Employees
4
Market Cap
48.98M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2023557.71K-431.33K-43.61%
Dec 31, 2022989.04K--
Dec 31, 2021---
Dec 31, 2020---
Dec 31, 2019---
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro
Dec 31, 2014 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Endo Inc. 1.79B
Veradigm 1.53B
SS Innovations International 16.04M
Elite Pharmaceuticals 71.17M
Glass House Brands 188.29M
Northwest Biotherapeutics 1.60M
BioStem Technologies 210.49M
Silence Therapeutics 21.77M
Revenue Rankings

Provectus Biopharmaceuticals News

More News